IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3′-kinase

Journal of Immunology

Volumn 167, Issue 8, 2001, Pages 4436-4442

  Zhou, J H ^a   Broussard, S R ^a   Strle, K ^a   Freund, G G ^a   Johnson, R W ^a   Dantzer, R ^a   Kelley, K W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RECOMBINANT INTERLEUKIN 10; STAT3 PROTEIN; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STEM CELL;

EID: 0035887654     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.8.4436     Document Type: Article

References (51)

1. IL-10 inhibits cytokine production by activated macrophages
2. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
3. Interleukin-10 and the interleukin-10 receptor
4. Interleukin-10 induces macrophage apoptosis and expression of CD16 (FcγRIII) whose engagement blocks the cell death programme and facilitates differentiation
5. Cytokine-modulated inhibition of neutrophil apoptosis at local site augments exudative neutrophil functions and reflects inflammatory response after surgery
6. IL-10 mediation of activation-induced th(1) cell apoptosis and lymphoid dysfunction in polymicrobial sepsis
7. Micro-environmental factors in the survival of human B-lymphoma cells
8. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell nonHodgkin's lymphoma to apoptosis
9. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins
10. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein
11. + hematopoietic progenitor cells
12. LPS/IFN-γ cytotoxicity in oligodendroglial cells: Role of nitric oxide and protection by the anti-inflammatory cytokine IL-10
13. Interleukin-10 and interleukin-13 inhibit proinflammatory cytokine-induced ceramide production through the activation of phosphatidylinositol 3-kinase
14. Identification and functional characterization of a second chain of the interleukin-10 receptor complex
15. Identification of the functional IL-TIF (IL-22) receptor complex: The IL-10R2 chain (IL- 10Rβ) is a shared component of both IL-10 and IL-TIF (IL-22) receptor complexes
16. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor
17. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STATI α and STAT3 complexes in human T cells and monocytes
18. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements
19. Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain
20. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
21. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons
22. Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor
23. Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells
24. JAK1-dependent phosphorylation of insulin receptor substrate-1 (IRS-1) is inhibited by IRS-1 serine phosphorylation
25. The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-α receptors
26. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-α
27. Phosphatidylinositol 3-kinase
28. The role of phosphoinositide 3-kinase lipid products in cell function
29. Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine
30. Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor
31. Phosphatidylinositol 3′-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors
32. A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide
33. Activation of phosphatidylinositol 3′-kinase by insulin-like growth factor-1 rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes
34. A receptor for interleukin 10 is related to interferon receptors
35. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor
36. Functional regions of the mouse interleukin-10 receptor cytoplasmic domain
37. Role of IRS-2 in insulin and cytokine signalling
38. The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action
39. Role of P13-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells
40. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway
41. Apoptosis suppression by Raf- 1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals
42. Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines
43. Neuroendocrine regulation of cytokine production during experimental influenza viral infection: Effects of restraint stress-induced elevation in endogenous corticosterone
44. IL-10 as a mediator in the HPA axis and brain
45. L
46. Cytokine-induced protein kinase B activation and Bad phosphorylation do not correlate with cell survival of hemopoietic cells
47. Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling
48. Proliferation of CECs requires dual signaling through both MAPK/ERK and PI 3-K/Akt pathways
49. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells
50. Mitogen-activated protein kinase (MAPK/ERK) overrides the apoptotic signaling fromFas, TNF, and TRAIL receptors
51. Extracellular-signal-regulated kinase signalling in neurons